2 seconds on that site look at this little tid bit! Pfizer’s Chemical/Biological Weapons Report
“Research on New Chemical Incapacitating Agents. Part 1.” By Chas. Pfizer and Co., Inc., under contract to the Army’s Chemical Research and Development Laboratories, 30 June 1964
Click here to download the report
(PDF format 65 pages 2.2 meg)
Right-click to save the file to your hard drive Mac users: Control-click to save
Back when the US had an openly acknowledged, offensive chemical-biological-radiological weapons program (as opposed to the secret, illegal one it has now), many pharmaceutical and chemical corporations developed these weapons for the military. Among them was drug giant Pfizer, whose better-known products include Viagra, Zoloft, Rogaine, and Rolaids.
In this 1964 report, the company (then called Chas. Pfizer & Co., Inc.) discusses its first year of research under its contract to create incapacitating agents, which produce tremors, dysphoria, confusion, muscle fatigue, pain, vomiting, diarrhea, difficulty breathing or swallowing, hypersensitive skin, dangerously low blood pressure, and/or - most intriguingly - retrograde amnesia. Despite the absence of the word biological from the report’s title, Pfizer also discusses its work with microbes in addition to chemicals.
The report was declassified on 16 April 2001, although it doesn’t appear to have made it to the general public until now. After seeing it listed in a bibliography I requested from the Defense Technical Information Center, I filed a FOIA request for it.
From pages 45-6 of the report: "Retrograde amnesia has been considered as a novel type of incapacitation that a drug may produce and was, therefore, included as a part of our research program.
Retrograde amnesia is the disruption of acquired information by a subsequent stimulus, usually traumatic. It may be produced in men by concussion, brain damage, acute cerebral anoxia, severe hypothermia and electroconvulsive shock.
The following considerations indicate that a chemical agent capable of inducing retrograde amnesia might be developed." [Approximately 17 lines of redaction follow.]
From page 56: "It is evident from the examples specified above that it is feasible to discover new incapacitating agents from microbial sources. In this regard, Chas. Pfizer & Co., Inc., is in a particularly advantageous position because of its vast background and experience in fermentation research.
The program will proceed initially along three lines. Firstly, some of the toxic compounds of microbiological origin, which are already available from the J.L. Smith Memorial for Cancer Research at Maywood, New Jersey, will be screened. Secondly, a number of substances of microbiological origin selected from the literature will be produced in our laboratories for similar evaluation. Lastly, those microbial cultures from Maywood known to produce especially toxic broths will undergo further scrutiny."
Some substances tested: thymol ethers, substituted 2-aminoimidazolines, quinazolones, dimethylhistamine, N-Nitrosopiperazine, amphetamines, pentobarbital sodium, Ditran, neostigmine, mescaline, carbochol, caffeine, nicotine, strychnine, LSD, psilocin, 5-HTP.
front page index + search
about contact blog donate
posted 20 June 2006
site and original text copyright 2002-6 Russ Kick